CLINICAL_TRIALS ClinicalTrials.gov record update

Companion Protocol for the ¹³C-Methacetin Breath Test Using the BreathID® MCS System for Conatus Phase 2 Study of Emricasan, an Oral Caspase Inhibitor, Under Protocol IDN-6556-14 (NCT02960204)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03439189
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:52.256503+00:00
Published At: 2020-09-04T00:00:00+00:00
Record Updated At: 2022-12-20
Results Posted At: 2020-09-04
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["NASH - Nonalcoholic Steatohepatitis", "Cirrhosis", "Portal Hypertension"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-12-20"
protocolSection.identificationModule.nctId: "NCT03439189"
protocolSection.identificationModule.officialTitle: "Companion Protocol for the \u00b9\u00b3C-Methacetin Breath Test Using the BreathID\u00ae MCS System for Conatus Phase 2 Study of Emricasan, an Oral Caspase Inhibitor, Under Protocol IDN-6556-14 (NCT02960204)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-09-04"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.